| Old Articles: <Older 17151-17160 Newer> |
|---|
 |
The Motley Fool
September 29, 2006
Brian Lawler |
Alpharma's Painless Results A new addition to an already successful drug promises good results for investors.   |
The Motley Fool
September 29, 2006
Ryan Fuhrmann |
Bassett Couches Another Quarter: Fool by Numbers The furniture maker released fiscal third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
September 29, 2006
Jack Uldrich |
iRobot: Bordering on Opportunity? iRobot -- by helping to secure our borders -- could be very well-positioned to receive some healthy government contracts. If so, the company and its investors could be bordering on a real opportunity. |
The Motley Fool
September 29, 2006
Ryan Fuhrmann |
Foolish Face-Off: Battle of the Soda Giants How do Pepsi and Coca-Cola rate, based on their numbers and their advertising slogans? Investors, take note. |
The Motley Fool
September 29, 2006
Brian Lawler |
Pfizer Helps France Kick Butts Europe approves the pharmaceutical's new drug to help smokers quit. Activities like this drug approval, and the molecule licensing earlier this week from privately held Quark Biotech, should eventually reignite Pfizer's moribund revenue growth. |
The Motley Fool
September 29, 2006
Anders Bylund |
TIBCO's Tip-Top Trade Tidings One company sees a shift in business software habits, right before its eyes. TIBCO doesn't expect an overnight revolution, but more of a long-term evolution. If you buy into the same vision and have a long-term investing horizon, TIBCO could serve you well. |
The Motley Fool
September 29, 2006
Jim Gillies |
A Health-Care Stock to Avoid Investors, before you leap in, keep in mind that not all health-care businesses are potential gold mines. Enter PolyMedica. |
The Motley Fool
September 29, 2006
Tim Beyers |
Robert Downey Jr.: Shellhead If handed a good script and smart guidance from Iron Man's director Jon Favreau, Downey should deliver at least as well as Fantastic Four did, and maybe even a lot better. Investors, take note. |
The Motley Fool
September 29, 2006
Seth Jayson |
Harvard Hypes Housing, but Why? A look behind the scenes at Harvard's Joint Center for Housing Studies might help explain the director's calm in the face of a bursting bubble. Investors, take care before you put too much faith in the prognostications of seemingly independent "academics." |
The Motley Fool
September 29, 2006
Rick Aristotle Munarriz |
Pretty as a Shutterfly? The photo-sharing site goes public, so investors -- keep an eye on its expenses. |
| <Older 17151-17160 Newer> Return to current articles. |
